Product Description

🔹 Product Overview
Erlonat 150 mg Tablet is a prescription anticancer medicine used in the treatment of certain types of cancer.
Contains Erlotinib 150 mg, a targeted therapy medicine that works by blocking cancer cell growth.
Commonly prescribed for non-small cell lung cancer (NSCLC) and pancreatic cancer under medical supervision.

🔹 Key Uses
Treatment of non-small cell lung cancer (NSCLC)
Management of pancreatic cancer
Helps slow the growth and spread of cancer cells
Used in targeted cancer therapy

🔹 Composition
Active ingredient: Erlotinib 150 mg
Belongs to tyrosine kinase inhibitor (TKI) class
Used in oncology treatment therapy

🔹 How It Works
Blocks epidermal growth factor receptor (EGFR) activity
Prevents cancer cell multiplication and spread
Helps control tumor growth in sensitive cancer cells

🔹 Key Benefits
Effective targeted cancer therapy tablet
Helps manage progression of certain cancers
Oral tablet formulation for convenient administration
Used as part of specialized oncology treatment plans

🔹 Dosage and Administration
Take as prescribed by an oncologist
Usually taken on an empty stomach
Swallow whole with water
Follow treatment schedule strictly for best results

🔹 Possible Side Effects
Skin rash
Diarrhea
Loss of appetite
Fatigue
Nausea

🔹 Precautions
Use under strict medical supervision
Regular monitoring may be required during treatment
Inform doctor about liver, lung, or kidney conditions
Avoid smoking, as it may reduce effectiveness
Not recommended during pregnancy unless advised by a doctor